Company profile for bioAffinity Technologies

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

bioAffinity Technologies, Inc. (NASDAQ: BIAF) addresses the urgent need for noninvasive, early-stage cancer diagnosis and targeted cancer treatment. Our first product, CyPath® Lung, accurately diagnoses early-stage lung cancer, the leading cause of cancer-related deaths, with the potential to dramatically increase overall diagnostic accuracy of lung cancer leading to increased survival, fewer unnecessary invasive procedures, ...
bioAffinity Technologies, Inc. (NASDAQ: BIAF) addresses the urgent need for noninvasive, early-stage cancer diagnosis and targeted cancer treatment. Our first product, CyPath® Lung, accurately diagnoses early-stage lung cancer, the leading cause of cancer-related deaths, with the potential to dramatically increase overall diagnostic accuracy of lung cancer leading to increased survival, fewer unnecessary invasive procedures, reduced patient anxiety, and lower medical costs.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
22211 W Interstate 10 Suite 1206 San Antonio, TX 7825
Telephone
Telephone
(210) 698-5334
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

BPI Europe

BPI Europe

Not Confirmed

envelop Contact Supplier

BPI Europe

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.pharmiweb.com/press-release/2026-04-14/new-case-study-bioaffinity-technologies-cypath-lung-diagnostic-supports-physician-s-assessment-p

PHARMIWEB
14 Apr 2026

https://www.pharmiweb.com/press-release/2026-04-07/bioaffinity-technologies-cypath-lung-to-be-featured-at-cleveland-clinic-annual-advances-in-early

PHARMIWEB
07 Apr 2026

https://www.pharmiweb.com/press-release/2026-03-25/bioaffinity-technologies-to-host-live-virtual-physician-roundtable-on-integrating-cypath-lung-into

PHARMIWEB
25 Mar 2026

https://www.businesswire.com/news/home/20260317808939/en/New-Case-Study-bioAffinity-Technologies-CyPath-Lung-Provides-Actionable-Results-and-Helps-Patient-Avoid-Costly-Invasive-Procedures

BUSSINESSWIRE
17 Mar 2026

https://www.pharmiweb.com/press-release/2026-03-13/bioaffinity-technologies-announces-record-2025-revenue-and-unit-sales-for-flagship-lung-cancer-diagn

PHARMIWEB
13 Mar 2026

https://www.pharmiweb.com/press-release/2026-03-10/bioaffinity-technologies-announces-initiation-of-large-scale-longitudinal-clinical-study-for-its-non

PHARMIWEB
10 Mar 2026

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty